Earlier as part of the guidelines for international travel, UK, Europe and West Asia were on the list, where passengers had to board with a negative RT-PCR report and get tested upon arrival.
The health ministry has asked states to implement the new guidelines and strengthen the whole genome sequencing activities. Talking about the latest variant Mu that has been classified by the World Health Organisation as a variant of interest, Balram Bhargava, director general, Indian Council of Medical Research, said, “We are closely observing it. So far it is not known to cause serious disease of rapid spread.”
Mu was first detected in South America’s Columbia region in January. “Mutants' risk will be there in future. Whatever the mutants, the tools of testing, tracking, treatment and vaccination are in hands and we have to use them against all mutants,” V K Paul, member-health Niti Aayog, said.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)